Skip to main content
BIIB
NASDAQ Life Sciences

Biogen's DZP Hits Primary Endpoint in Late-Stage Lupus Trial

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$248.35
Mkt Cap
$36.711B
52W Low
$151.83
52W High
$258.78
52W Position info
64% above low
Off High info
4.0% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BIIB sits 64% above its 52-week low of $151.83.

Summary

Biogen said DZP plus standard of care met the primary endpoint of BICLA response at week 48, with SRI-4 response of 60% versus 41%. That is a clean win on the primary measure with a supportive secondary, the kind of topline that supports a regulatory filing. The readout lands as Biogen's lupus pipeline gains credibility, following the 52-week Phase 2 litifilimab data reported October 2nd showing continued improvement in cutaneous lupus. Biogen is trading near its 52-week high after a Q3 beat on October 28th, so this adds a second late-stage immunology asset to a story the market has already been rewarding.

At the time of this announcement, BIIB was trading at $248.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $36.7B. The 52-week trading range was $151.83 to $258.78. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

BIIB - Latest Insights

BIIB
Oct 28, 2026, 6:23 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $254.87 info
Change: +$2.14 (+0.85%) info
Market Cap: $37.675B info
BIIB
Oct 28, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $254.87 info
Change: +$2.14 (+0.85%) info
Market Cap: $37.675B info
BIIB
Oct 28, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $252.73
Real-time Price: $254.87 info
Change: +$2.14 (+0.85%) info
Market Cap: $37.675B info
BIIB
Oct 02, 2026, 11:20 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $221.12
Real-time Price: $254.87 info
Change: +$33.75 (+15%) info
Market Cap: $37.675B info
BIIB
Sep 16, 2026, 2:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $216.17
Real-time Price: $254.87 info
Change: +$38.70 (+18%) info
Market Cap: $37.675B info